Liao Yingqin, Li Zhonghong, Shu Zhaohui, Zhong Xiaoyi, Su Yongshao, Ma Zhichao, Liu Peiqing, Lu Jing, Zang Linquan, Pan Xuediao, Zhou Sigui
Department of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China.
Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, Guangdong, China. Corresponding author: Zhou Sigui, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Feb;31(2):172-177. doi: 10.3760/cma.j.issn.2095-4352.2019.02.010.
To Study the changes of short-chain acyl-CoA dehydrogenase (SCAD) in heart failure (HF) after myocardial infarction (MI), and the effect of aerobic exercise on SCAD.
Healthy male Sprague-Dawley (SD) rats were divided into sham operation group (Sham group), sham operation swimming group (Sham+swim group), HF model group (LAD group) and HF swimming group (LAD+swim group) by random number table method, with 9 rats in each group. The left anterior descending branch of coronary artery (LAD) was ligated to establish a rat model of HF after MI. In Sham group, only one loose knot was threaded under the left coronary artery, and the rest operations were the same as those in LAD group. Rats in Sham+swim group and LAD+swim group were given swimming test for 1 week after operation (from 15 minutes on the 1st day to 60 minutes on the 5th day). Then they were given swimming endurance training (from the 2nd week onwards, 60 minutes daily, 6 times weekly, 10 weeks in a row). Tail artery systolic pressure (SBP) was measured before swimming endurance training and every 2 weeks until the end of the 10th week. Ten weeks after swimming training, echocardiography was performed to measure cardiac output (CO), stroke volume (SV), left ventricular ejection fraction (LVEF), shortening fraction (FS), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic volume (LVESV), and left ventricular end-diastolic volume (LVEDV). Morphological changes of heart were observed by Masson staining. Apoptosis of myocardial cells was detected by transferase-mediated deoxyuridine triphosphate-biotin nick end labeling stain (TUNEL) and apoptosis index (AI) was calculated. Reverse transcription-polymerase chain reaction (RT-PCR) and Western Blot were used to detect the mRNA and protein expression of myocardial SCAD respectively. In addition, the enzyme activity of SCAD, the content of adenosine triphosphate (ATP) and free fatty acid (FFA) in serum and myocardium were detected according to the kit instruction steps.
Compared with Sham group, Sham+swim group showed SBP did not change significantly, with obvious eccentric hypertrophy and increased myocardial contractility, and LAD group showed persistent hypotension, obvious MI, thinning of left ventricle, and decreased myocardial systolic/diastolic function. Compared with LAD group, SBP, systolic/diastolic function and MI in LAD+swim group were significantly improved [SBP (mmHg, 1 mmHg = 0.133 kPa): 119.5±4.4 vs. 113.2±4.5 at 4 weeks, 120.3±4.0 vs. 106.5±3.7 at 6 weeks, 117.4±1.3 vs. 111.0±2.3 at 8 weeks, 126.1±1.6 vs. 119.4±1.9 at 10 weeks; CO (mL/min): 59.10±6.31 vs. 33.19±4.76, SV (μL): 139.42±17.32 vs. 84.02±14.26, LVEF: 0.523±0.039 vs. 0.309±0.011, FS: (28.17±2.57)% vs. (15.93±3.64)%, LVEDD (mm): 8.80±0.19 vs. 9.35±0.30, LVESD (mm): 5.90±0.77 vs. 7.97±0.60, LVEDV (μL): 426.57±20.84 vs. 476.24±25.18, LVESV (μL): 209.50±25.18 vs. 318.60±16.10; AI: (20.4±1.4)% vs. (31.2±4.6)%; all P < 0.05]. Compared with Sham group, the mRNA and protein expression of myocardium SCAD, the activity of SCAD in Sham+swim group were significantly increased, the content of ATP was slightly increased, the content of serum FFA was significantly decreased, and the content of myocardial FFA was slightly decreased; conversely, the mRNA and protein expression of myocardium SCAD, the activity of SCAD and the content of ATP in LAD group were significantly decreased, the content of serum and myocardial FFA were significantly increased. Compared with LAD group, the mRNA and protein expression of myocardium SCAD, the content of ATP were significantly increased in LAD+swim group [SCAD mRNA (2): 0.52±0.16 vs. 0.15±0.01, SCAD/GAPDH (fold increase from Sham group): 0.94±0.08 vs. 0.60±0.11, ATP content (μmol/g): 52.8±10.1 vs. 14.7±6.1, all P < 0.05], the content of serum and myocardial FFA were significantly decreased [serum FFA (nmol/L): 0.11±0.03 vs. 0.29±0.04, myocardial FFA (nmol/g): 32.7±8.2 vs. 59.7±10.7, both P < 0.05], and the activity of SCAD was slightly increased (kU/g: 12.3±4.3 vs. 8.9±5.8, P > 0.05).
The expression of SCAD in HF was significantly down-regulated, and the expression was significantly up-regulated after aerobic exercise intervention, indicating that swimming may improve the severity of HF by up-regulating the expression of SCAD.
研究心肌梗死后心力衰竭(HF)时短链酰基辅酶A脱氢酶(SCAD)的变化,以及有氧运动对SCAD的影响。
将健康雄性Sprague-Dawley(SD)大鼠按随机数字表法分为假手术组(Sham组)、假手术游泳组(Sham+游泳组)、HF模型组(LAD组)和HF游泳组(LAD+游泳组),每组9只。结扎冠状动脉左前降支(LAD)建立心肌梗死后HF大鼠模型。Sham组仅在左冠状动脉下穿一个松结,其余操作同LAD组。Sham+游泳组和LAD+游泳组大鼠术后进行1周游泳试验(第1天15分钟,第5天60分钟)。然后给予游泳耐力训练(从第2周开始,每天60分钟,每周6次,连续10周)。在游泳耐力训练前及训练至第10周结束时每2周测量尾动脉收缩压(SBP)。游泳训练10周后,行超声心动图检查测量心输出量(CO)、每搏输出量(SV)、左心室射血分数(LVEF)、缩短分数(FS)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、左心室收缩末期容积(LVESV)和左心室舒张末期容积(LVEDV)。采用Masson染色观察心脏形态学变化。采用末端脱氧核苷酸转移酶介导的生物素-脱氧尿苷三磷酸缺口末端标记染色(TUNEL)检测心肌细胞凋亡,并计算凋亡指数(AI)。采用逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹法(Western Blot)分别检测心肌SCAD的mRNA和蛋白表达。此外,按照试剂盒说明书步骤检测SCAD的酶活性、血清及心肌中三磷酸腺苷(ATP)和游离脂肪酸(FFA)的含量。
与Sham组相比,Sham+游泳组SBP无明显变化,有明显离心性肥大且心肌收缩力增强,LAD组出现持续性低血压、明显心肌梗死、左心室变薄及心肌收缩/舒张功能降低。与LAD组相比,LAD+游泳组SBP、收缩/舒张功能及心肌梗死情况均显著改善[SBP(mmHg,1 mmHg = 0.133 kPa):4周时119.5±4.4比113.2±4.5,6周时120.3±4.0比106.5±3.7,8周时117.4±1.3比111.0±2.3,10周时126.1±1.6比119.4±1.9;CO(mL/min):59.10±6.31比33.19±4.76,SV(μL):139.42±17.32比84.02±14.26,LVEF:0.523±0.039比0.309±0.011,FS:(28.17±2.57)%比(15.93±3.64)%,LVEDD(mm):8.80±0.19比9.35±0.30,LVESD(mm):5.90±0.77比7.97±0.60,LVEDV(μL):426.57±20.84比476.24±25.18,LVESV(μL):209.50±25.18比318.60±16.10;AI:(20.4±1.4)%比(31.2±4.6)%;均P < 0.05]。与Sham组相比,Sham+游泳组心肌SCAD的mRNA和蛋白表达、SCAD活性显著增加,ATP含量略有增加,血清FFA含量显著降低,心肌FFA含量略有降低;相反,LAD组心肌SCAD的mRNA和蛋白表达、SCAD活性及ATP含量显著降低,血清和心肌FFA含量显著增加。与LAD组相比,LAD+游泳组心肌SCAD的mRNA和蛋白表达、ATP含量显著增加[SCAD mRNA(2):0.52±0.16比0.15±0.01,SCAD/GAPDH(相对于Sham组增加倍数):0.94±0.08比0.60±0.11,ATP含量(μmol/g):52.8±10.1比14.7±6.1,均P < 0.05],血清和心肌FFA含量显著降低[血清FFA(nmol/L):0.11±0.03比0.29±0.04,心肌FFA(nmol/g):32.7±8.2比59.7±10.7,均P < 0.05],SCAD活性略有增加(kU/g:12.3±4.3比8.9±5.8,P > 0.05)。
HF时SCAD表达显著下调,有氧运动干预后表达显著上调,提示游泳可能通过上调SCAD表达改善HF严重程度。